Efficacy of Yisui granule on myelodysplastic syndromes in SKM-1 mouse xenograft model through suppressing Wnt/ β-catenin signaling pathway

CONCLUSIONS: Our findings demonstrated that YSG could be used alone or in combination with decitabine to improve outcomes in the MDS animal model, providing an alternative solution for treating MDS.PMID:38213242 | PMC:PMC10774724 | DOI:10.19852/j.cnki.jtcm.20231204.003
Source: Journal of Traditional Chinese Medicine - Category: Complementary Medicine Authors: Source Type: research